What is the other name for tirzepatide in Spain?

In Spain, tirzepatide is marketed as Mounjaro rather than Zepbound, which is the US brand name used for weight management. The most reliable way to confirm this is to check the official product information for the EU authorised medicine.

Are Tirzepatide and another name the same in all countries?

Tirzepatide is the name of the active ingredient, and names like Mounjaro or Zepbound are brand names. That's why a traveler might see different names online and think they're different medications, when in reality they're referring to the same compound.

In the European Union, the drug containing tirzepatide, authorized and described in regulatory documentation, is marketed under the name Mounjaro. In the United States, the regulator also recognizes tirzepatide under two brand names, one for type 2 diabetes and the other for weight management.

Is Zepbound tirzepatide or something else?

Zepbound is a brand name whose active ingredient is tirzepatide, according to public communication from the U.S. regulator. This means that when someone asks about Zepbound, they are essentially asking about tirzepatide marketed under that name.

In Spain, the practical reference in pharmacies and official documentation is Mounjaro, because that is the name used to identify the medicine authorized in the EU. If someone is looking for Zepbound in Spain, it's helpful to translate their question to tirzepatide and Mounjaro, not the American brand name.

What is Mounjaro authorized for in the EU and what does this mean for Spain?

The European product information for Mounjaro includes indications for both type 2 diabetes and weight management, always in conjunction with lifestyle modifications. This is an important point because it explains why a second brand name is not needed in Europe for the same active ingredient.

In Spain, in addition to authorization, there is publicly available information about its funding status, which can influence the final cost to the patient. This difference between authorization and funding is a frequent source of confusion for tourists and newly arrived residents.

How to avoid confusion and risky purchases when searching for "another name"?

The first rule is not to buy online based solely on the brand, because the counterfeit market grows precisely when there is high demand for weight loss or diabetes medications. European agencies have warned of illegal online sales and profiles that impersonate well-known brands.

The second rule is to rely on regulatory sources, such as the EMA's Mounjaro fact sheet or information from CIMA and AEMPS for Spain. This avoids mixing brand names with rumors about availability and ensures you understand what is actually dispensed in pharmacies.

This text is for informational purposes only and does not replace medical advice. Always consult the official package leaflet and follow the instructions of your doctor or pharmacist.